Savvy Updates, 9/26/22: Medtronic Pumps & Cybersecurity Risk, Diabeloop Algorithm Increases TIR, T1D & UTIs, Moderate Diabetes Distress Even with CGM
FDA Warns of Cybersecurity Risk With Medtronic MiniMed 600 Series Insulin Pumps was reported by David Kerr, MD, for Healio.com/endocrinology, 20 September 2022. The FDA has issued an alert warning people with diabetes using a Medtronic MiniMed 630G or MiniMed 670G...
Savvy Updates, 9/19/22: Investor Lawsuit against Medtronic, Synthetic Human Gut Microbiome, Sex of Researcher Affects Study Outcomes, Loss of “Caring” in Healthcare
Investor lawsuit accuses Medtronic of failing to disclose insulin pump problems was posted by Mick Paul Taylor for MedTechDive.com, 13 September 2022. Investors have accused Medtronic of failing to disclose problems with its insulin pump business that...
Savvy Updates 9/12/22: Novo saves Zegalogue, Sugar Disrupts Microbiome, Cravings for Fatty Foods, DPAC Sues HHS for Copay Accumulators, Best Places for Dexcom G6 Sensor
Zealand summons Novo Nordisk to resuscitate floundering diabetes newcomer Zegalogue was reported by Fraiser Kansteiner for FiercePharma.com, 7 September 2022. Zealand said it has forged a global license and development pact with Novo Nordisk to take the marketing...
Savvy Updates, 9/6/22: Senseonics CFO Leaves, Beta Bionics Trial Data & RIF, Chip-free, Wireless Electronic Skin, Insulin Pill, Cognitive Benefits from Hybrid Closed Loop Systems, Sugar & Microbiome, T1D & Hypothyroidism
Senseonics Announces CFO Transition was published by Senseonics Holdings, Inc., 1 September 2022. Senseonics, a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems...
More Diabetes Blogs